How to buy Zoetis (ZTS) shares in Australia
Learn how to easily invest in Zoetis shares.
Zoetis Inc (ZTS) is a leading drug manufacturers - specialty & generic business with stocks listed in the US. It opened the day at US$176.25 after a previous close of US$176.67. During the day the price has varied from a low of USD175.98 to a high of USD179.46. The latest price was USD179.13 (25 minute delay). Zoetis is listed on the NYSE. All prices are listed in US Dollars.
How to buy shares in Zoetis
- Compare share trading platforms. To buy shares in a company listed in the US from Australia you'll need to find a trading platform that offers access to US stock markets. Look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, which will typically include your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Zoetis. Find the share by name or ticker symbol: ZTS. Research its history to confirm it's a solid investment that matches your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Zoetis reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying using consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$176.67, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Zoetis, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Zoetis. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights.
What's in this guide?
Zoetis stock price (NYSE:ZTS)Use our graph to track the performance of ZTS stocks over time.
Zoetis shares at a glance
|52-week range||US$139.4877 - US$194.5243|
|50-day moving average||US$171.369|
|200-day moving average||US$173.792|
|Dividend yield||US$1.45 (0.84%)|
|Earnings per share (TTM)||US$4.92|
Zoetis price performance over time
|1 week (2023-11-22)||-0.12%|
|1 month (2023-11-03)||10.42%|
|3 months (2023-09-01)||-6.96%|
|6 months (2023-06-02)||4.22%|
|1 year (2022-12-02)||13.79%|
|2 years (2021-12-03)||-19.79%|
|3 years (2020-12-03)||14.04%|
|5 years (2018-12-03)||91.44%|
Compare trading platforms to buy Zoetis shares
Is it a good time to buy Zoetis stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Is Zoetis under- or over-valued?
Valuing Zoetis stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Zoetis's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Zoetis's P/E ratio
Zoetis's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 36x. In other words, Zoetis shares trade at around 36x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Zoetis's PEG ratio
Zoetis's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 3.5264. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Zoetis's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Zoetis's EBITDA (earnings before interest, taxes, depreciation and amortisation) is US$3.5 billion (£2.7 billion).
The EBITDA is a measure of a Zoetis's overall financial performance and is widely used to measure a its profitability.
Zoetis share price volatility
Over the last 12 months, Zoetis's shares have ranged in value from as little as US$139.4877 up to US$194.5243. A popular way to gauge a stock's volatility is its "beta".
Beta measures a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Zoetis's is 0.823. This would suggest that Zoetis's shares are less volatile than average (for this exchange).
|Revenue TTM||US$8.4 billion|
|Operating margin TTM||37.1%|
|Gross profit TTM||US$5.6 billion|
|Return on assets TTM||13.76%|
|Return on equity TTM||46.78%|
|Market capitalisation||US$82.1 billion|
TTM: trailing 12 months
Zoetis share dividends
Dividend payout ratio: 28.68% of net profits
Recently Zoetis has paid out, on average, around 28.68% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.84% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Zoetis shareholders could enjoy a 0.84% return on their shares, in the form of dividend payments. In Zoetis's case, that would currently equate to about $1.45 per share.
While Zoetis's payout ratio might seem fairly standard, it's worth remembering that Zoetis may be investing much of the rest of its net profits in future growth.
Zoetis's most recent dividend payout was on 1 December 2023. The latest dividend was paid out to all shareholders who bought their shares by 31 October 2023 (the "ex-dividend date").
Zoetis's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Zoetis.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Zoetis's total ESG risk score
Total ESG risk: 28.6
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Zoetis's overall score of 28.6 (as at 01/01/2019) is nothing to write home about – landing it in it in the 49th percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Zoetis is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Zoetis's environmental score
Environmental score: 2.72/100
Zoetis's environmental score of 2.72 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Zoetis is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Zoetis's social score
Social score: 13/100
Zoetis's social score of 13 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Zoetis is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Zoetis's governance score
Governance score: 8.87/100
Zoetis's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Zoetis is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Zoetis's controversy score
Controversy score: 1/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Zoetis scored a 1 out of 5 for controversy – the highest score possible, reflecting that Zoetis has managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||28.6|
|Total ESG percentile||49.38|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||1|
Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses. The company also offers parasiticides; vaccines; anti-infectives; other pharmaceutical products; dermatology; and medicated feed additives. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products and laboratory; and other non-pharmaceutical products. It markets its products to veterinarians, livestock producers, and pet owners. The company was founded in 1952 and is headquartered in Parsippany, New Jersey.
Stocks similar to Zoetis
Frequently asked questions
More guides on Finder
How to buy OpenAI stock in Australia
Looking to jump on the AI bandwagon? Here's how you can invest in ChatGPT and its parent company OpenAI from Australia.
Best performing stocks on the ASX in 2023 (Updated weekly)
Looking for the best performing stocks in Australia? We update this list weekly.
Cryptocurrency ETFs explained: A simple guide for investors (2023)
If you’re looking for ways to gain exposure to Bitcoin and other digital currencies, cryptocurrency ETFs could be worth exploring. Find out what crypto ETFs are and how they work in this introductory guide.
How to buy Gol Linhas Aereas Inteligentes SA ADR (GOL) shares in Australia
Steps to owning and managing Gol Linhas Aéreas Inteligentes SA shares from Australia.
How to buy Microsoft (MSFT) shares in Australia
Steps to owning and managing Microsoft shares from in Australia.
A beginner’s guide to Lego investing
Looking for alternative investments? With a ROI of up to 3,593% lego may be worth considering. Read on to find out which lego sets are worth the investment.
The cheapest stock brokers in Australia (Dec 2023)
Find cheap stock brokerage in Australia when buying and selling shares on the ASX and other international exchanges.
What is the money market?
Learn about the money market and everyday consumer money market products.
Is investing in crowdfunding a safe investment?
Equity crowdfunding offers a unique opportunity for investors and for Australian startups, but Australia’s regulatory framework surrounding crowdfunding still lags behind the rest of the world.
The best trading platforms in Australia for 2023
Follow these tips to find the best share trading platform for you.
Ask an Expert